TSPAN8 and colorectal cancer: Consequently, TSPAN8 inhibition, which has been successfully tested for ovarian and colorectal cancer with TSPAN8 inhibitory antibodies 16, 17, may be advantageous for therapy of TSPAN8 metastases.